[HTML][HTML] Anti-obesity drug discovery: advances and challenges

TD Müller, M Blüher, MH Tschöp… - Nature Reviews Drug …, 2022 - nature.com
Enormous progress has been made in the last half-century in the management of diseases
closely integrated with excess body weight, such as hypertension, adult-onset diabetes and …

[HTML][HTML] Signaling pathways in obesity: mechanisms and therapeutic interventions

X Wen, B Zhang, B Wu, H Xiao, Z Li, R Li… - Signal transduction and …, 2022 - nature.com
Obesity is a complex, chronic disease and global public health challenge. Characterized by
excessive fat accumulation in the body, obesity sharply increases the risk of several …

[HTML][HTML] Pharmacological treatment of hyperglycemia in type 2 diabetes

SI Taylor, ZS Yazdi… - The Journal of clinical …, 2021 - Am Soc Clin Investig
Diabetes mellitus is a major public health problem, affecting about 10% of the population.
Pharmacotherapy aims to protect against microvascular complications, including blindness …

[HTML][HTML] An increase in the omega-6/omega-3 fatty acid ratio increases the risk for obesity

AP Simopoulos - Nutrients, 2016 - mdpi.com
In the past three decades, total fat and saturated fat intake as a percentage of total calories
has continuously decreased in Western diets, while the intake of omega-6 fatty acid …

Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly

P Pacher, S Steffens, G Haskó, TH Schindler… - Nature Reviews …, 2018 - nature.com
Dysregulation of the endogenous lipid mediators endocannabinoids and their G-protein-
coupled cannabinoid receptors 1 and 2 (CB1R and CB2R) has been implicated in a variety …

Molecular pathways in non-alcoholic fatty liver disease

A Berlanga, E Guiu-Jurado, JA Porras… - Clinical and …, 2014 - Taylor & Francis
Non-alcoholic fatty liver disease (NAFLD) is a clinicopathological change characterized by
the accumulation of triglycerides in hepatocytes and has frequently been associated with …

Targeting the endocannabinoid system: to enhance or reduce?

V Di Marzo - Nature reviews Drug discovery, 2008 - nature.com
As our understanding of the endocannabinoids improves, so does the awareness of their
complexity. During pathological states, the levels of these mediators in tissues change, and …

Cannabinoids and the gut: new developments and emerging concepts

AA Izzo, KA Sharkey - Pharmacology & therapeutics, 2010 - Elsevier
Cannabis has been used to treat gastrointestinal (GI) conditions that range from enteric
infections and inflammatory conditions to disorders of motility, emesis and abdominal pain …

Endocannabinoid signaling as a synaptic circuit breaker in neurological disease

I Katona, TF Freund - Nature medicine, 2008 - nature.com
Cannabis sativa is one of the oldest herbal plants in the history of medicine. It was used in
various therapeutic applications from pain to epilepsy, but its psychotropic effect has …

Anti-obesity therapy: from rainbow pills to polyagonists

TD Müller, C Clemmensen, B Finan, RD DiMarchi… - Pharmacological …, 2018 - ASPET
With their ever-growing prevalence, obesity and diabetes represent major health threats of
our society. Based on estimations by the World Health Organization, approximately 300 …